United States (US) Compounding Pharmacies Market (2025-2031) | Companies, Competitive Landscape, Industry, Outlook, Size & Revenue, Segmentation, Growth, Share, Value, Analysis, Trends, Forecast

Name: United States (US) Compounding Pharmacies Market (2025-2031) | Companies & Competitive Landscape
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Therapeutic Area (Hormone Replacement Therapy, Pain Management, Specialty Drugs, Dermatology, Nutritional Supplements, Others), By Age Cohort (Pediatric, Adult, Geriatric), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), Others) And Competitive Landscape

Product Code: ETC9963074	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Compounding Pharmacies Market Outlook
Market Size of United States (US) Compounding Pharmacies Market, 2024
Forecast of United States (US) Compounding Pharmacies Market, 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Revenues & Volume for the Period 2021- 2031
United States (US) Compounding Pharmacies Market Trend Evolution
United States (US) Compounding Pharmacies Market Drivers and Challenges
United States (US) Compounding Pharmacies Price Trends
United States (US) Compounding Pharmacies Porter's Five Forces
United States (US) Compounding Pharmacies Industry Life Cycle
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Therapeutic Area for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Hormone Replacement Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Pain Management for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Specialty Drugs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Dermatology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Nutritional Supplements for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Age Cohort for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Pediatric for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Adult for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Geriatric for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Compounding Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Pharmaceutical Ingredient Alteration (PIA) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Currently Unavailable Pharmaceutical Manufacturing (CUPM) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Pharmaceutical Dosage Alteration (PDA) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Compounding Pharmacies Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Compounding Pharmacies Import Export Trade Statistics
Market Opportunity Assessment By Therapeutic Area
Market Opportunity Assessment By Age Cohort
Market Opportunity Assessment By Compounding Type
United States (US) Compounding Pharmacies Top Companies Market Share
United States (US) Compounding Pharmacies Competitive Benchmarking By Technical and Operational Parameters
United States (US) Compounding Pharmacies Company Profiles
United States (US) Compounding Pharmacies Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Compounding Pharmacies Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Compounding Pharmacies Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Compounding Pharmacies Market - Industry Life Cycle

3.4 United States (US) Compounding Pharmacies Market - Porter's Five Forces

3.5 United States (US) Compounding Pharmacies Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F

3.6 United States (US) Compounding Pharmacies Market Revenues & Volume Share, By Age Cohort, 2021 & 2031F

3.7 United States (US) Compounding Pharmacies Market Revenues & Volume Share, By Compounding Type, 2021 & 2031F

4 United States (US) Compounding Pharmacies Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medication

4.2.2 Growing prevalence of chronic diseases

4.2.3 Rising healthcare expenditure in the US

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for compounding pharmacies

4.3.2 Limited insurance coverage for compounded medications

4.3.3 Potential safety concerns associated with compounded drugs

5 United States (US) Compounding Pharmacies Market Trends

6 United States (US) Compounding Pharmacies Market, By Types

6.1 United States (US) Compounding Pharmacies Market, By Therapeutic Area

6.1.1 Overview and Analysis

6.1.2 United States (US) Compounding Pharmacies Market Revenues & Volume, By Therapeutic Area, 2021- 2031F

6.1.3 United States (US) Compounding Pharmacies Market Revenues & Volume, By Hormone Replacement Therapy, 2021- 2031F

6.1.4 United States (US) Compounding Pharmacies Market Revenues & Volume, By Pain Management, 2021- 2031F

6.1.5 United States (US) Compounding Pharmacies Market Revenues & Volume, By Specialty Drugs, 2021- 2031F

6.1.6 United States (US) Compounding Pharmacies Market Revenues & Volume, By Dermatology, 2021- 2031F

6.1.7 United States (US) Compounding Pharmacies Market Revenues & Volume, By Nutritional Supplements, 2021- 2031F

6.1.8 United States (US) Compounding Pharmacies Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Compounding Pharmacies Market, By Age Cohort

6.2.1 Overview and Analysis

6.2.2 United States (US) Compounding Pharmacies Market Revenues & Volume, By Pediatric, 2021- 2031F

6.2.3 United States (US) Compounding Pharmacies Market Revenues & Volume, By Adult, 2021- 2031F

6.2.4 United States (US) Compounding Pharmacies Market Revenues & Volume, By Geriatric, 2021- 2031F

6.3 United States (US) Compounding Pharmacies Market, By Compounding Type

6.3.1 Overview and Analysis

6.3.2 United States (US) Compounding Pharmacies Market Revenues & Volume, By Pharmaceutical Ingredient Alteration (PIA), 2021- 2031F

6.3.3 United States (US) Compounding Pharmacies Market Revenues & Volume, By Currently Unavailable Pharmaceutical Manufacturing (CUPM), 2021- 2031F

6.3.4 United States (US) Compounding Pharmacies Market Revenues & Volume, By Pharmaceutical Dosage Alteration (PDA), 2021- 2031F

6.3.5 United States (US) Compounding Pharmacies Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Compounding Pharmacies Market Import-Export Trade Statistics

7.1 United States (US) Compounding Pharmacies Market Export to Major Countries

7.2 United States (US) Compounding Pharmacies Market Imports from Major Countries

8 United States (US) Compounding Pharmacies Market Key Performance Indicators

8.1 Number of new customized formulations developed

8.2 Patient satisfaction rates with compounded medications

8.3 Percentage of healthcare providers recommending compounding pharmacies

9 United States (US) Compounding Pharmacies Market - Opportunity Assessment

9.1 United States (US) Compounding Pharmacies Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F

9.2 United States (US) Compounding Pharmacies Market Opportunity Assessment, By Age Cohort, 2021 & 2031F

9.3 United States (US) Compounding Pharmacies Market Opportunity Assessment, By Compounding Type, 2021 & 2031F

10 United States (US) Compounding Pharmacies Market - Competitive Landscape

10.1 United States (US) Compounding Pharmacies Market Revenue Share, By Companies, 2024

10.2 United States (US) Compounding Pharmacies Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Compounding Pharmacies Market

Botswana Compounding Pharmacies Market

Brunei Compounding Pharmacies Market

Bulgaria Compounding Pharmacies Market

Burkina Faso Compounding Pharmacies Market

Burundi Compounding Pharmacies Market

Global Compounding Pharmacies Market

Middle East Compounding Pharmacies Market

North America Compounding Pharmacies Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here